Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Korean diabetic patients with dyslipidemia
NCT01239849Phase 4
Key facts
- Status
- Unknown
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Countries
- 1
- Sponsor
- The Catholic University of Korea
- Modality
- Small Molecules
- Drugs
- atorvastatin
- Conditions
- hypercholesterolemia
01
Overview
Phase 4, open-label trial of atorvastatin in hypercholesterolemia, sponsored by The Catholic University of Korea. Primary endpoint: Percentage of subjects achieving LDL cholesterol target at 8 weeks. Status: unknown.
02
Design
- Study design
- Non-randomizedOpen-label
03
Who it enrols
Korean diabetic patients aged 18-80 with dyslipidemia (LDL 100-220 mg/dl) and controlled diabetes (HbA1c <= 12%).
04
Endpoints
Primary
Percentage of subjects achieving LDL cholesterol target
Beyond the preview
Go deeper on NCT01239849.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239849.